• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Elife . Redirection of SARS-CoV-2 to phagocytes by intranasal sACE2-Fc as a universal decoy confers complete prophylactic protection

tetano

Editor, Senior Moderator
Elife


. 2026 May 18:14:RP108883.
doi: 10.7554/eLife.108883.
Redirection of SARS-CoV-2 to phagocytes by intranasal sACE2-Fc as a universal decoy confers complete prophylactic protection

Jingyi Wang[SUP] #[/SUP][SUP] 1 [/SUP], Jiangchuan Li[SUP] #[/SUP][SUP] 1 [/SUP], Alex W H Chin[SUP] #[/SUP][SUP] 2 3 [/SUP], Bin Luo[SUP] 1 4 [/SUP], Junkang Wei[SUP] 1 [/SUP], Jiale Qiu[SUP] 1 [/SUP], Jianwei Ren[SUP] 1 4 [/SUP], Yin Xia[SUP] 1 [/SUP], Thomas Braun[SUP] 1 5 [/SUP], Leo L M Poon[SUP] 2 3 6 [/SUP], Bo Feng[SUP] 1 4 7 [/SUP]


Affiliations
Abstract

The rapid evolution of SARS-CoV-2 and other respiratory RNA viruses limits the success of current vaccines and antibody-based therapies. Engineered decoy receptors based on soluble angiotensin-converting enzyme 2 (sACE2) offer promising alternatives but show limited clinical success. This study conducted functional and mechanistic analyses using an optimized sACE2 mutant fused to human IgG1 Fc (B5-D3) as a representative, revealing redirection of virus-decoy complexes from epithelial infection to lysosomal degradation in phagocytes beyond viral neutralization. Intranasal prophylactic delivery of B5-D3 confers complete protection in SARS-CoV-2-infected K18-hACE2 mice, regardless of age. Abrogation of Fc effector functions compromises antiviral protection, indicating that Fc-mediated uptake of virus-decoy complexes is critical. Transcriptomic analysis suggests that B5-D3 induces early immune activation in the lungs of infected mice. Bio-distribution and flow cytometry reveal selective targeting of airway phagocytes. In vitro assays confirm lysosomal degradation of virus-decoy complexes by macrophages without productive infection. These findings reveal a distinct antiviral mechanism via phagocytic clearance, supporting refined regimens for decoy treatments against SARS-CoV-2 and potentially other respiratory viruses.

Keywords: ACE2-Fc decoy; SARS-CoV-2; immunology; infectious disease; inflammation; intranasal prophylactics; macrophages; microbiology; viruses.

 
Back
Top